142 related articles for article (PubMed ID: 2066275)
1. Viral antibody titers, immunogenetic markers, and their interrelations in multiple sclerosis patients and controls.
Alpérovitch A; Berr C; Cambon-Thomsen A; Puel J; Dugoujon JM; Ruidavets JB; Clanet M
Hum Immunol; 1991 Jun; 31(2):94-9. PubMed ID: 2066275
[TBL] [Abstract][Full Text] [Related]
2. Viral infection in patients with multiple sclerosis and HLA-DR matched controls.
Compston DA; Vakarelis BN; Paul E; McDonald WI; Batchelor JR; Mims CA
Brain; 1986 Apr; 109 ( Pt 2)(2):325-44. PubMed ID: 3456817
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis.
Ilonen J; Reunanen M; Salmi A; Tiilikainen A
J Neurol Sci; 1981 Jan; 49(1):117-33. PubMed ID: 6259296
[TBL] [Abstract][Full Text] [Related]
4. A division of HLA-DQw1 associated with DR1, DR1x-DQw1, DR2 short, DRw10, and DRw14. I. Definition by alloantiserum LY 1327.
Gebuhrer L; Betuel H; Lambert J; Freidel AC; Farre A
Hum Immunol; 1987 Mar; 18(3):235-45. PubMed ID: 2437088
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis in north-east Scotland. An association with HLA-DQw1.
Francis DA; Batchelor JR; McDonald WI; Hing SN; Dodi IA; Fielder AH; Hern JE; Downie AW
Brain; 1987 Feb; 110 ( Pt 1)():181-96. PubMed ID: 3492235
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin GM and KM genes and measles vaccine-induced humoral immunity.
Ovsyannikova IG; Larrabee BR; Schaid DJ; Poland GA
Vaccine; 2017 Oct; 35(41):5444-5447. PubMed ID: 28274637
[TBL] [Abstract][Full Text] [Related]
7. Immunogenetic analysis and serum viral antibody titers in multiple sclerosis.
Whitaker JN; Herrmann KL; Rogentine GN; Stein SF; Kollins LL
Arch Neurol; 1976 Jun; 33(6):399-403. PubMed ID: 938263
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis, sleep latencies and HLA antigens.
Rumbach L; Tongio MM; Warter JM; Collard M; Kurtz D
J Neurol; 1989 Jul; 236(5):309-10. PubMed ID: 2760651
[TBL] [Abstract][Full Text] [Related]
9. DR2/DQw1 inheritance and haplotype sharing in affected siblings from multiple sclerosis families.
Voskuhl RR; Goldstein AM; Simonis T; Davey RJ; McFarland HF
Ann Neurol; 1996 Jun; 39(6):804-7. PubMed ID: 8651654
[TBL] [Abstract][Full Text] [Related]
10. Histocompatibility types and measles antibodies in multiple sclerosis.
Fewster ME; Myers LW; Ellison GW; Walford RL
J Neurol Sci; 1977 Nov; 34(2):287-96. PubMed ID: 925715
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; James JA
Mult Scler; 2013 Jun; 19(7):891-5. PubMed ID: 23232601
[TBL] [Abstract][Full Text] [Related]
12. Some specific human leukocyte antigen (HLA)-DR/DQ haplotypes are more important than individual HLA-DR and -DQ phenotypes for the development of mucocutaneous type of Behçet's disease and for disease shift from recurrent aphthous stomatitis to mucocutaneous type of Behçet's disease.
Sun A; Hsieh RP; Chu CT; Wang JT; Liu BY; Chiang CP
J Oral Pathol Med; 2001 Aug; 30(7):402-7. PubMed ID: 11488417
[TBL] [Abstract][Full Text] [Related]
13. The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer.
Spurkland A; Celius EG; Knutsen I; Beiske A; Thorsby E; Vartdal F
Tissue Antigens; 1997 Jul; 50(1):15-22. PubMed ID: 9243750
[TBL] [Abstract][Full Text] [Related]
14. Virus-specific cytotoxic T cells in multiple sclerosis.
McFarland HF; Goodman A; Jacobson S
Ann N Y Acad Sci; 1988; 532():273-9. PubMed ID: 3263072
[No Abstract] [Full Text] [Related]
15. HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis--their relation to disease progression.
Eberhardt K; Grubb R; Johnson U; Pettersson H
J Rheumatol; 1993 Nov; 20(11):1825-9. PubMed ID: 8308765
[TBL] [Abstract][Full Text] [Related]
16. Class II HLA antigens in multiple sclerosis.
Miller DH; Hornabrook RW; Dagger J; Fong R
J Neurol Neurosurg Psychiatry; 1989 May; 52(5):575-7. PubMed ID: 2732726
[TBL] [Abstract][Full Text] [Related]
17. An immunogenetic heterogeneity in multiple sclerosis.
Hillert J; Grönning M; Nyland H; Link H; Olerup O
J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):887-90. PubMed ID: 1359021
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive viral immunology of multiple sclerosis. II. Analysis of serum and CSF antibodies by standard serologic methods.
Cremer NE; Johnson KP; Fein G; Likosky WH
Arch Neurol; 1980 Oct; 37(10):610-5. PubMed ID: 6252874
[TBL] [Abstract][Full Text] [Related]
19. Antibody titers by mixed agglutination to varicella-zoster, herpes simplex and vaccinia viruses in patients with multiple sclerosis.
Ito M; Barron AL; Olszewski WA; Milgrom F
Proc Soc Exp Biol Med; 1975 Sep; 149(4):835-9. PubMed ID: 170625
[TBL] [Abstract][Full Text] [Related]
20. Serological and molecular studies of HLA in Sardinian patients with Graves' disease.
La Nasa G; Martino E; Carcassi C; Mulargia M; Floris L; Vacca A; Baldini G; Orrù S; Ledda A; Grasso L
Dis Markers; 1991; 9(6):307-12. PubMed ID: 1823309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
